⚲
|
Great Point Partners LLC
✚
| |
---|---|
CRD # | 158423 |
SEC # | 801-73834 |
CIK # | 0001281446 |
AUM | $2.0 BB (2024-03-28) |
Employees | 28 (82% Investors, 11% Brokers) |
Phone | 203-971-3300 |
Address | 165 Mason Street Greenwich, CT 06830 |
Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
Total AUM ($BB) |
---|
CIK | Period |
---|---|
0001281446 | |
/ |
Sector | Form 13F Holdings | Cap ($MM) | Value ($MM) |
---|---|---|---|
UroGen Pharma Ltd | 181.1 | 48.8 | |
Aquinox Pharmaceuticals Inc | 36.5 | ||
Abivax Sa | 32.7 | ||
Merus NV | 941.6 | 31.0 | |
Pliant Therapeutics Inc | 277.1 | 28.3 | |
Arcellx Inc | 782.5 | 27.2 | |
Dynavax Technologies Corp | 1,537.2 | 26.7 | |
Evolus Inc | 665.3 | 26.6 | |
Cytokinetics Inc | 4,051.3 | 25.7 | |
Magenta Therapeutics Inc | 19.6 | ||
Insmed Inc | 2,379.6 | 16.8 | |
JATT Acquisition Corp | 16.2 | ||
Carbylan Therapeutics Inc | 236.1 | 15.8 | |
ISIS Pharmaceuticals Inc | 5,384.1 | 15.7 | |
Context Therapeutics Inc | 35.9 | 14.9 | |
Amicus Therapeutics Inc | 2,969.6 | 14.8 | |
Optinose Inc | 304.3 | 14.3 | |
Esperion Therapeutics Inc | 395.1 | 12.9 | |
Voyager Therapeutics Inc | 221.5 | 12.7 | |
Autolus Therapeutics PLC | 258.2 | 12.0 | |
Amplitude Healthcare Acquisition Corp | 76.5 | 9.1 | |
Olema Pharmaceuticals Inc | 175.1 | 8.6 | |
Terns Pharmaceuticals Inc | 60.7 | 7.8 | |
Signal Genetics Inc | 293.2 | 6.5 | |
TScan Therapeutics Inc | 74.0 | 5.5 | |
Vistagen Therapeutics Inc | 188.0 | 5.3 | |
Innovative Acquisitions Corp | 125.0 | 4.8 | |
Prev | Page 1 | Next |
Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
---|---|---|---|---|
PE | GPP - CF I LP | [2023-03-31] | 36.4 | 29.6 |
PE | GPP III - Ephicacy LLC | 2023-03-31 | 20.8 | |
PE | GPP III - Ixcells LLC | 2023-03-31 | 1.6 | |
PE | Great Point Partners IV LP | [2022-05-05] | 432.0 | 534.9 |
PE | GPP III - PCM LLC | 2022-03-31 | 31.3 | |
PE | GPP II-A Salmon AIV LP | 2021-02-25 | 20.6 | |
PE | GPP III - MLM LLC | 2021-02-25 | 5.3 | |
PE | Great Point Partners II Salmon AIV LP | 2021-02-25 | 67.1 | |
PE | GPP III - Axiom LLC | 2020-03-30 | 14.7 | |
PE | GPP III - Bionova LLC | 2020-03-30 | 0.1 | |
View All |
AUM Breakdown | Accounts | AUM ($BB) |
---|---|---|
By Client Type | ||
(a) Individuals (other than high net worth individuals) | 0 | 0.0 |
(b) Individuals (high net worth individuals) | 0 | 0.0 |
(c) Banking or thrift institutions | 0 | 0.0 |
(d) Investment companies | 0 | 0.0 |
(e) Business development companies | 0 | 0.0 |
(f) Pooled investment vehicles | 19 | 1.9 |
(g) Pension and profit sharing plans | 0 | 0.0 |
(h) Charitable organizations | 0 | 0.0 |
(i) State or municipal government entities | 0 | 0.0 |
(j) Other investment advisers | 1 | 0.1 |
(k) Insurance companies | 0 | 0.0 |
(l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
(m) Corporations or other businesses not listed above | 0 | 0.0 |
(n) Other | 0 | 0.0 |
Total | 20 | 2.0 |
By Discretionary | ||
Discretionary | 20 | 2.0 |
Non-Discretionary | 0 | 0.0 |
Total | 20 | 2.0 |
By Non-United States Persons | ||
Non-United States Persons | 0.4 | |
United States Persons | 1.6 | |
Total | 20 | 2.0 |
Form D Directors | # Filings | # Firms | 2011 - 2024 |
---|---|---|---|
Riyaz Nooruddin | 53 | ||
Alan Kelly | 36 | ||
Jeffrey Jay | 12 | ||
David Kroin | 5 | ||
Great Point Partners LLC | 3 | ||
Great Point GP LLC | 2 | ||
Great Point Partners CF I GP LLC | 1 |
EDGAR Form | CIK | 2011 - 2024 |
---|---|---|
13F-HR | [0001281446] | |
13F-NT | [0001281446] | |
3 | [0001281446] | |
4 | [0001281446] | |
SC 13D | [0001281446] | |
SC 13G | [0001281446] |
Comparable Firms | State | AUM ($BB) |
---|---|---|
Mount Logan Management LLC
✚
|
NY | 2.1 |
Newmarket Investment Management LP
✚
|
PA | 2.1 |
Theorem Partners LLC
✚
|
CA | 2.0 |
Medalist Partners LP
✚
|
NY | 2.0 |
Skybridge Capital II LLC
✚
|
NY | 2.0 |
Soleus Capital Management LP
✚
|
CT | 2.0 |
Fir Tree Capital Management LP
✚
|
NY | 2.0 |
Conversant Capital LLC
✚
|
NJ | 1.9 |
Tensile Capital Management LP
✚
|
CA | 1.9 |
Glouston Capital Partners LLC
✚
|
MA | 1.9 |